Arcellx And Kite Announce Strategic Collaboration To Co-Develop And Co-Commercialize Late-Stage Clinical CART-DdBCMA In Multiple Myeloma

Published on :

Arcellx, Inc. (NASDAQ: ACLX) and Kite, a Gilead Company (NASDAQ: GILD), today announced a global strategic collaboration to co-develop and co-commercialize Arcellx’s lead late-stage product candidate, CART-ddBCMA, for the treatment of patients with relapsed or refractory multiple myeloma.  Multiple myeloma is an incurable disease for most patients and the need remains for effective, safe, and broadly accessible therapies.

In Conversation: Trushar Agrawal, Senior Director and Head of Manufacturing at Kite Pharma

Published on :

This past summer, Kite promoted biotech industry veteran Trushar Agrawal from his Director of QA role to Senior Director, Head of Manufacturing for the Frederick site. Agrawal will work to bring on new team members as the site ramps up commercial production of its CAR T-cell therapy product, which is used to treat people living with blood cancer. 

Kite Hosts Cell Therapy Hiring Event at Growing Frederick, Maryland Facility

Published on :

The “Onsite at Kite” event, which was held on World Lymphoma Awareness Day, featured networking opportunities, a facility tour, and panel discussion with site leadership, during which job seekers and industry professionals learned about Kite’s patient focus in manufacturing. 

Kite Pharma Invests in Maryland’s Workforce Development Programming

Published on :

Kite’s choice to plant roots in Maryland has been a boon to the economy and the region’s life sciences ecosystem. Kite has committed to building strong partnerships with the local community across an array of key constituencies, including workforce development initiatives at local universities and life sciences support organizations. Kite’s goal is to augment existing workforce development programming and to help the region continue building a thriving life sciences workforce. 

Kite Launches Program to Attract and Hire Veterans

Published on :

Kite’s cell manufacturing facility in Frederick has recently launched what it calls its Veteran Pathways Program. The program is led by veteran hiring program strategist Bre Cameron. Cameron is a Navy veteran with more than a decade of experience in talent acquisition. 

Top Biotech Companies Hiring in Maryland: Summer 2022 Edition

Published on :

Here’s our Summer 2022 Roundup of top Maryland life sciences companies with more than 10 active job listings across a wide range of fields and experience levels. 

Five Maryland Companies That Are Powering The Cell and Gene Therapy Revolution

Published on :

Here are just five of the many Maryland companies that stand out for their unique technologies and solutions that are responsible for driving progress in the cell and gene therapy field and helping their partners bring their products through the clinic and to the patients that need them.